SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-072503
Filing Date
2020-06-12
Accepted
2020-06-11 17:58:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A tm2022403-1_s3a.htm S-3/A 204218
2 EXHIBIT 23.1 tm2022403d1_ex23-1.htm EX-23.1 2252
3 GRAPHIC tm2022403-1_s3aimg001.jpg GRAPHIC 4615
4 GRAPHIC tm2022403-1_s3aimg01.jpg GRAPHIC 5029
  Complete submission text file 0001104659-20-072503.txt   221274
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-235399 | Film No.: 20958224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances